chr19-16744556-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001007525.5(NWD1):c.334G>A(p.Glu112Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,535,704 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001007525.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NWD1 | NM_001007525.5 | c.334G>A | p.Glu112Lys | missense_variant | 5/19 | ENST00000524140.7 | NP_001007526.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NWD1 | ENST00000524140.7 | c.334G>A | p.Glu112Lys | missense_variant | 5/19 | 1 | NM_001007525.5 | ENSP00000428579.2 |
Frequencies
GnomAD3 genomes AF: 0.000644 AC: 98AN: 152138Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000123 AC: 17AN: 138452Hom.: 0 AF XY: 0.0000533 AC XY: 4AN XY: 75040
GnomAD4 exome AF: 0.0000593 AC: 82AN: 1383448Hom.: 0 Cov.: 33 AF XY: 0.0000542 AC XY: 37AN XY: 682630
GnomAD4 genome AF: 0.000644 AC: 98AN: 152256Hom.: 0 Cov.: 31 AF XY: 0.000591 AC XY: 44AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.334G>A (p.E112K) alteration is located in exon 5 (coding exon 3) of the NWD1 gene. This alteration results from a G to A substitution at nucleotide position 334, causing the glutamic acid (E) at amino acid position 112 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at